Dr. Rachel Brem Appointed Delphinus Medical Technologies BOD

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

July 31, 2019

Dr. Rachel Brem has joined Delphinus Medical Technologies board of directors, effective immediately.

Dr. Rachel Brem is one of the nation’s most renowned radiologists and experts on breast imaging and intervention. She is currently the Director, Breast Imaging and Intervention at The George Washington University and the Program Leader, Breast Cancer, at The George Washington Cancer Center. She also serves as the Director of the Breast Imaging and Intervention Fellowship and Vice-Chair for Research and Faculty Development in the Department of Radiology at The George Washington University.

“We are thrilled to have Dr. Rachel Brem join our board of directors. Dr. Brem is an innovative leader in the field of breast cancer imaging and detection, a passionate patient advocate, and a pioneering radiologist who has helped to establish new imaging modalities and guidelines to detect breast cancer earlier in order to save lives,” said Delphinus Medical Technologies President and CEO, Mark Forchette. “Dr. Brem brings tremendous knowledge, vision and energy to Delphinus, and her insights to advancing clinical thought and practice will be invaluable as we move our SoftVue™ technology through the regulatory pathway. We are excited to have her expert counsel as we advance though clinical and regulatory targets in support of a supplemental screening indication for women with dense breasts in combination with mammography.”

Dr. Rachel Brem is founder of the Brem Foundation to Defeat Breast Cancer, an organization with the mission to maximize women’s chances of finding curable breast cancer through expert education, access to diagnostic tests, and physician training. Dr. Brem played a key role in the development of Computer Aided Design (CAD) and was involved in the first FDA cleared artificial intelligence product for mammography. In addition, she is actively involved in the advancement of Automated Breast Ultrasound Systems (ABUS), Molecular Breast Imaging (MBI) and Magnetic Resonance Imaging (MRI) as supplemental breast imaging modalities.

Dr. Brem earned her medical degree from Columbia University. She completed her internship in internal medicine at the Sinai Hospital of Baltimore and her residency in radiology at the Johns Hopkins Hospital. She pursued further training in magnetic resonance imaging and breast imaging as a fellow at Johns Hopkins Medical institutions.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.